CyThera

CyThera is involved with the development of cell replacement therapies for degenerative diseases and are focusing on Type 1 Diabetes.

History:

CyThera has completed their acquisition of Arcos BioScience, presumably ending the conflict over the "blessed" stem cell lines.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: private

Employees:

Regions:
Southern California

Research Focus:
Development Disease Therapeutics-Research

 

Profiles: BioScorpio CHI

 

News:

Keywords: 

Strategic Partnerships: